Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: RON is not a prognostic marker for resectable pancreatic cancer

Figure 2

Optimization of RON immunohistochemical staining. Immunohistochemical staining of RON in MIA PaCa-2 and Panc 10.05 cell lines (A and B), using IgG rabbit and anti-RON primary antibodies in pancreatic cancer tissues (C and D), and in benign ductal cells of the pancreas and in breast cancer with high RON expression (E and F), at low and high magnification. Examples of absent, low, moderate to high RON staining in pancreatic cancer tissue are also shown (G-J).

Back to article page